Evaluation status available after sign-in
About the journal
Journal of Cancer Policy is a journal published by Elsevier BV in Netherlands. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 2,910 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 2213-5383
- Country
- Netherlands
- Access
- Not open access / not declared
- Declared publication charge
- 2,910 USD
- Declared peer-review model
- peer_review
- Official website
- https://www.journals.elsevier.com/journal-of-cancer-policy
Index listings
- MEDLINE · 2021-01-01
- PUBMED · 2014-09-01
- Indexing
- MEDLINE · PUBMED
- APC
- 2,910 USD
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 94 days received→accepted — computed from PubMed (n=99)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
745
Last recorded publication year
2026
Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
29
i10-index
146
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 95%
- ORCID iDs in current deposits
- 68%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- JCPO
- Source type
- journal
- NLM unique ID (PubMed)
- 101639933
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- Economic and Financial Impacts of Cancer
- Economic and Financial Impacts of Cancer
- Economic and Financial Impacts of Cancer
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
Show all subjects (75)
- Health Systems, Economic Evaluations, Quality of Life
- Advances in Oncology and Radiotherapy
- Advances in Oncology and Radiotherapy
- Advances in Oncology and Radiotherapy
- Women's cancer prevention and management
- Cancer survivorship and care
- Pharmaceutical Economics and Policy
- Cancer survivorship and care
- Cancer survivorship and care
- Cervical Cancer and HPV Research
- Cervical Cancer and HPV Research
- Cervical Cancer and HPV Research
- Health Policy Implementation Science
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Screening and Detection
- Pharmaceutical Economics and Policy
- Healthcare Systems and Practices
- Palliative Care and End-of-Life Issues
- Pharmaceutical Economics and Policy
- Palliative Care and End-of-Life Issues
- Pharmaceutical industry and healthcare
- Global Health and Surgery
- Colorectal Cancer Screening and Detection
- Global Health and Surgery
- Healthcare Systems and Reforms
- Childhood Cancer Survivors' Quality of Life
- Childhood Cancer Survivors' Quality of Life
- Healthcare Quality and Management
- COVID-19 and healthcare impacts
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Global Public Health Policies and Epidemiology
- COVID-19 and healthcare impacts
- COVID-19 and healthcare impacts
- Palliative Care and End-of-Life Issues
- Health and Medical Research Impacts
- Palliative and Oncologic Care
- Healthcare Policy and Management
- Science, Research, and Medicine
- Healthcare Systems and Reforms
- Statistical Methods in Clinical Trials
- BRCA gene mutations in cancer
- Ethics in Clinical Research
- BRCA gene mutations in cancer
- Statistical Methods in Clinical Trials
- Statistical Methods in Clinical Trials
- Ethics in Clinical Research
- Healthcare Systems and Reforms
- Biomedical Ethics and Regulation
- Global Health and Surgery
- Head and Neck Cancer Studies
- Biomedical Ethics and Regulation
- Biomedical Ethics and Regulation
- Head and Neck Cancer Studies
- Head and Neck Cancer Studies
- Global Public Health Policies and Epidemiology
- Global Public Health Policies and Epidemiology
- Pharmaceutical industry and healthcare
- Pharmaceutical industry and healthcare
- Cancer Risks and Factors
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Healthcare cost, quality, practices
- Healthcare cost, quality, practices
- Medication Adherence and Compliance
- Cancer Risks and Factors
- Smoking Behavior and Cessation
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ